China's foreign investment policies are empowering biomedical enterprises to expand domestically and globally. CGTN's Xu Hua explores how China's initiatives are driving innovation amid global trade uncertainties. 

XU HUA, Shenzhen "China continues to welcome foreign investment – and its biomedical sector, including pet healthcare – is set to grow and expand."

Joey Yeo is among hundreds of international business leaders touring south China's Guangdong Province this week. As the founder of two pet healthcare startups in Shanghai, Joey leverages China's pro-FDI measures.

JOEY YEO, Managing Director, Heal (Shanghai) Pet Service Medical, CEO, HEAL Vettcare Technologies "I think the openness with the local government and the business district has been very fruitful."

With streamlined approvals and regulatory guidance, Joey's company plans to scale operations across multiple cities.

JOEY YEO, Managing Director, Heal (Shanghai) Pet Service Medical, CEO, HEAL Vettcare Technologies "Not just Shanghai, but we used to see other cities as well coming to us and asking us, giving us more opportunities and more understanding how we can actually set a bigger landscape."

Joey's story reflects broader trends: China's FDI policies have reduced entry barriers, while banks like BEA offer tailored financial solutions.

BI MINGQIANG, CEO, Bank of East Asia (China) "I don't think any multinational company or foreign investors can ignore the huge market capacity, the huge potential of greater China. We are going through the fin-tech transformation and by adapting AI, big data, block chains, those kind of technology, we can better help those SMEs in need."

As China prioritizes openness, biomedical firms and financial institutions are forging a symbiotic growth model, proving resilient in a fragmented global economy. Xu Hua, CGTN, Shenzhen, Guangdong Province.